White House announces $200M in organ donation research investments

In an effort to reduce the waiting list for organ donation, the administration of President Barack Obama announced several new actions at a White House summit June 13.

The majority of the $200 million in research investments will be available through an effort at the U.S. Department of Defense (DOD). The $160 million public-private investment will focus on developing new manufacturing techniques to replace and repair cells and tissues, which may lead to organ replacement.

Among the other awards announced by the White House:

·         $15 million from the Cystic Fibrosis Foundation to improving outcomes after lung transplantation

·         $7 million from the American Society of Nephrology for a potential Kidney Disease XPRIZE

·         $4.2 million from the Laura and John Arnold Foundation to “test donor interventions that maximize the quantity and quality of life-saving organs that each donor is able to give”

Beyond research funding, companies like Facebook and Twitter will launch advocacy campaigns to make it easier to become an organ donor, with the goal of registering 1 million new donors.

The White House said moving organ donation registration away from relying solely on states’ motor vehicles departments could close a large gap between the 95 percent of Americans who support organ donation and the roughly 50 percent who are actually registered donors.

Some of the efforts also hinge on advances in health IT. More than 30 transplant centers announced they’ll collaborate on a kidney transplant data-sharing initiative, and the United Network for Organ Sharing (UNOS) said it would increase efficiency in its systems for will increase efficiencies in the organ procurement through new and open technology. 

 

""
John Gregory, Senior Writer

John joined TriMed in 2016, focusing on healthcare policy and regulation. After graduating from Columbia College Chicago, he worked at FM News Chicago and Rivet News Radio, and worked on the state government and politics beat for the Illinois Radio Network. Outside of work, you may find him adding to his never-ending graphic novel collection.

Around the web

CMS finalized a significant policy change when it increased the Medicare payments hospitals receive for performing CCTA exams. What, exactly, does the update mean for cardiologists, billing specialists and other hospital employees?

Stryker, a global medtech company based out of Michigan, has kicked off 2025 with a bit of excitement. The company says Inari’s peripheral vascular portfolio is highly complementary to its own neurovascular portfolio.

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.